HIV/AIDS Screening
EIA is acceptable for HIV surveillance in urine samples of high-risk populations
Published in AIDS Weekly, February 14th, 2005
"A cross-sectional study was conducted to evaluate the utility of a commercial enzyme immunoassay (EIA) as a screening test for detecting HIV-1 antibody in urine in a population at risk for HIV infection in Catalonia, Spain.
"Paired urine and serum samples were collected consecutively from 99 patients who attended two drug-dependency treatment centers and 151 patients who attended a sexually transmitted diseases (STD) clinic in Barcelona," scientists in Spain report.
"Antibodies against HIV in urine samples were detected...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-02-14)
More Articles from AIDS Weekly
- HIV/AIDS Pathogenesis
Conserved residues in HIV-1 gp41 coiled-coil pocket essential for replication - HIV/AIDS Therapy
Recent studies add new data to HIV/AIDS therapy research - HIV/AIDS-Related Dementia
Predictive model developed for AIDS dementia complex - HIV/AIDS-Related Neuropathy
Erythropoietin is neuroprotective in HIV sensory neuropathy models - Toxoplasma Gondii
PCR detects Toxoplasma gondii in the CSF of HIV-infected patients - Acute Myelogenous Leukemia 1
Hematopoietic potential of AML1 closely related to its transcriptional activity - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
